United Therapeutics (UTHR) dives 11.8% after yesterday saying that the FDA has turned down the...

|About: United Therapeutics Corpo... (UTHR)|By:, SA News Editor

United Therapeutics (UTHR) dives 11.8% after yesterday saying that the FDA has turned down the company's new drug application for treprostinil, an oral treatment for high blood pressure. The agency is uncertain whether another study would help change its mind, but said that if UTHR does decide on a further trial, it should consider a fixed dose design and more frequent dosing. (PR)